Skip to main content
Premium Trial:

Request an Annual Quote

Virogenomics and OHSU Receive $100K NIH Grant

NEW YORK, May 30 - NIH has awarded Virogenomics and Oregon Health & Science a phase I Small Business Technology Transfer grant to develop new anti-HIV drugs.

 

The $99,808 grant from the National Institute of Allergy and Infectious Diseases will be used to continue Virogenomics-sponsored research by OHSU scientists.

 

The researchers aim to identify novel cellular drug targets by gene expression profiling and validate them through target-specific gene silencing techniques developed by Virogenomics and OHSU.

 

Virogenomics, an OHSU spinoff based in Portland, Ore., was founded in 2001.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.